Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 22;368(6):fnab038.
doi: 10.1093/femsle/fnab038.

Short-chain fatty acid and fecal microbiota profiles are linked to fibrosis in primary biliary cholangitis

Affiliations

Short-chain fatty acid and fecal microbiota profiles are linked to fibrosis in primary biliary cholangitis

Craig Lammert et al. FEMS Microbiol Lett. .

Abstract

The gut microbiota and metabolome could play a role in primary biliary cholangitis (PBC) progression. We aimed to assess fecal microbiota and fecal short-chain fatty acids (SCFAs) in PBC according to fibrosis. In a cross-sectional study of 23 PBC patients, fecal microbiota and SCFAs were determined using 16S rRNA sequencing and nuclear magnetic resonance spectroscopy, respectively. Fecal acetate and SCFAs were higher in advanced fibrosis. Advanced fibrosis microbiota exhibited decreased alpha diversity, increased Weisella and a distinct community composition. SCFAs correlated with individual taxa in non-advanced fibrosis. Fecal microbiota and SCFAs correspond to fibrosis in PBC.

Keywords: acetate; butyrate; metabolome; microbiome; primary biliary cirrhosis; propionate.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Fecal microbiota (A) alpha diversity with Shannon diversity index, (B) alpha diversity with Faith's phylogenetic diversity index and (C) beta diversity using unweighted UniFrac distances are associated with fibrosis group.
Figure 2.
Figure 2.
Correlations between fecal acetate and relative abundance of (A)Lachnospiraceae group NK4A136 and (B)Collinsella.

Similar articles

Cited by

References

    1. Abe K, Takahashi A, Fujita Met al. . Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease. PLoS One. 2018;13:e0198757. - PMC - PubMed
    1. Amathieu R, Triba MN, Goossens Cet al. . Nuclear magnetic resonance based metabolomics and liver diseases: recent advances and future clinical applications. World J Gastroenterol. 2016;22:417–26. - PMC - PubMed
    1. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289–300.
    1. Chen W, Wei Y, Xiong Aet al. . Comprehensive analysis of serum and fecal bile acid profiles and interaction with gut microbiota in primary biliary cholangitis. Clin Rev Allergy Immunol. 2020;58:25–38. - PubMed
    1. Flint HJ, Duncan SH, Scott KPet al. . Links between diet, gut microbiota composition and gut metabolism. Proc Nutr Soc. 2015;74:13–22. - PubMed

Publication types

MeSH terms